Trina Racine

Dr. Trina Racine received her PhD in Microbiology and Immunology from Dalhousie University in 2010. She then joined the Special Pathogens Program at the National Microbiology Laboratory, part of the Public Health Agency of Canada. While at the NML Dr. Racine worked on the development of vaccines and therapeutics for various emerging and re-emerging infectious diseases, including Ebola, Zika and MERS. Dr. Racine has coordinated clinical trials and has provided diagnostic support to the Ebola outbreak in West Africa in 2014-2016. Prior to joining VIDO, Dr. Racine was a Scientific and Regulatory Affairs Consultant for GeneOne Life Science, Inc., a South Korean based biopharmaceutical company.